View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
Guy Sips ... (+5)
  • Guy Sips
  • Hilde Van Boxstael
  • Jacob Mekhael
  • Thomas Vranken
  • Wim Lewi
Florent Laroche-Joubert ... (+2)
  • Florent Laroche-Joubert
  • Roy Külter

ODDO : La baisse des taux d’intérêt favorise l’immobilier : nos top pi...

Le maintien d’un environnement baissier des taux d’intérêt devrait être porteur pour le secteur immobilier en 2025 et lui permettre de continuer à surperformer. Dans ce contexte, nous privilégions le commerce et le résidentiel allemand , qualifiés de «safe haven» et plus spécifiquement Covivio, CTP, Merlin Properties, URW, Vonovia et Xior Student Housing pour un potentiel moyen de +30%. Elles sont les plus à même pour nous d’exécuter leur stratégie de croissance / repositionnement. Nous abaisson...

Florent Laroche-Joubert ... (+2)
  • Florent Laroche-Joubert
  • Roy Külter

ODDO : Interest rate winds favor real estate: Our top picks for 2025

An environment of further interest rate decline is set to underpin the real estate sector in 2025 and see it continue to outperform. On this basis, we prefer retail and the German residential market, which are seen as safe havens, more specifically Covivio, CTP, Merlin Properties, URW, Vonovia and Xior Student Housing for an average upside of +30%. They are the best positioned, as we see it, to execute their growth/repositioning strategies. We have downgraded Branicks, Cofinimmo, Icade and Patr...

Jacob Mekhael ... (+4)
  • Jacob Mekhael
  • Michiel Declercq
  • Thomas Vranken
  • Wim Lewi
Wim Lewi
  • Wim Lewi

Shurgard New central Rotterdam permit

Shurgard received a building permit for a new self-storage building located in the centre of Rotterdam. The future c. 3,300 sqm freehold self-storage facility will offer over 800 self-storage units and is set to open end of 2025. Direct project cost is estimated at EUR 9.1m and the property yield at maturity is expected to be c. 9%. We like that Shurgard continues its development activities in 1 of its 4 core regions as most of the attention and fear of the market has focussed on the LnS acquisi...

 PRESS RELEASE

Ageas reports on the progress of share buy-back programme

Ageas reports on the progress of share buy-back programme Further to the initiation of the share buy-back programme announced on 28 August 2024, Ageas reports the purchase of 21,749 Ageas shares in the period from 23-12-2024 until 27-12-2024. DateNumber ofSharesTotal amount(EUR)Average price(EUR)Lowest price(EUR)Highest price(EUR)23-12-20248,321383,15546.0545.8046.1224-12-2024-----25-12-2024-----26-12-20247,613352,51846.3046.1046.4027-12-20245,815268,46646.1745.9446.52Total21,7491,004,14046.1745.8046.52 Since the start of the share buy-back programme on 16 September 2024, Ageas has bought b...

 PRESS RELEASE

Ageas rapporteert over de inkoop van eigen aandelen

Ageas rapporteert over de inkoop van eigen aandelen Naar aanleiding van het aandelen-inkoopprogramma dat op 28 augustus 2024 aangekondigd werd, maakt Ageas bekend dat er 21.749 eigen aandelen ingekocht werden tussen 23-12-2024 en 27-12-2024. DatumAantalaandelenTotaal Bedrag(EUR)Gemiddelde koers(EUR)Laagste koers(EUR)Hoogste koers(EUR)23-12-20248.321383.15546,0545,8046,1224-12-2024-----25-12-2024-----26-12-20247.613352.51846,3046,1046,4027-12-20245.815268.46646,1745,9446,52Totaal21.7491.004.14046,1745,8046,52 Vanaf de start van het aandelen-inkoopprogramma op 16 september 2024 heeft Ageas ee...

 PRESS RELEASE

Ageas reports on the progress of share buy-back programme

Ageas reports on the progress of share buy-back programme Further to the initiation of the share buy-back programme announced on 28 August 2024, Ageas reports the purchase of 50,094 Ageas shares in the period from 16-12-2024 until 20-12-2024. DateNumber ofSharesTotal amount(EUR)Average price(EUR)Lowest price(EUR)Highest price(EUR)16-12-20249,450448,07347.4247.3047.7817-12-20249,234433,16346.9146.7047.3218-12-20249,690449,62146.4046.1046.9219-12-20249,720447,01445.9945.7046.1820-12-202412,000550,18745.8545.5446.20Total50,0942,328,05846.4745.5447.78 Since the start of the share buy-back progr...

 PRESS RELEASE

Rapport d’Ageas sur le programme de rachat d’actions

Rapport d’Ageas sur le programme de rachat d’actions Dans le cadre du programme de rachat d’actions annoncé le 28 août 2024, Ageas indique que 50.094 actions Ageas ont été achetées durant la période du 16-12-2024 au 20-12-2024. DateNombred’actionsMontant total(EUR)Cours moyen(EUR)Cours le plus bas (EUR)Cours le plus élevé (EUR)16-12-20249.450448.07347,4247,3047,7817-12-20249.234433.16346,9146,7047,3218-12-20249.690449.62146,4046,1046,9219-12-20249.720447.01445,9945,7046,1820-12-202412.000550.18745,8545,5446,20Total50.0942.328.05846,4745,5447,78 Depuis le lancement du programme de rachat d’a...

 PRESS RELEASE

Ageas rapporteert over de inkoop van eigen aandelen

Ageas rapporteert over de inkoop van eigen aandelen Naar aanleiding van het aandelen-inkoopprogramma dat op 28 augustus 2024 aangekondigd werd, maakt Ageas bekend dat er 50.094 eigen aandelen ingekocht werden tussen 16-12-2024 en 20-12-2024. DatumAantalaandelenTotaal Bedrag(EUR)Gemiddelde koers(EUR)Laagste koers(EUR)Hoogste koers(EUR)16-12-20249.450448.07347,4247,3047,7817-12-20249.234433.16346,9146,7047,3218-12-20249.690449.62146,4046,1046,9219-12-20249.720447.01445,9945,7046,1820-12-202412.000550.18745,8545,5446,20Totaal50.0942.328.05846,4745,5447,78 Vanaf de start van het aandelen-inkoop...

 PRESS RELEASE

Ageas and The Goldman Sachs Group, Inc:  Transparency notification

Ageas and The Goldman Sachs Group, Inc:  Transparency notification In accordance with the rules on financial transparency*, The Goldman Sachs Group, Inc has notified Ageas on 13 December 2024 that, on 9 December 2024, its interest has fallen below the legal threshold of 5% of the shares issued by Ageas. On 12 December 2024 it notified Ageas that, on 6 December 2024, its interest has fallen below the statutory threshold of 3% of shares issued by Ageas in box A (Voting rights). Its current shareholding stands at 0.35%. Reason for the notification of 13 December 2024Acquisition or disposal of...

 PRESS RELEASE

Ageas et The Goldman Sachs Group, Inc: Notification de transparence

Ageas et The Goldman Sachs Group, Inc: Notification de transparence Conformément aux règles de transparence financière*, The Goldman Sachs Group, Inc a introduit le 13 décembre 2024 une notification annonçant que le 9 décembre 2024, sa participation a franchi à la baisse le seuil légal de 5% des actions émises par Ageas. Le 12 décembre 2024, il a introduit une notification annonçant que le 6 décembre 2024, sa participation a franchi à la baisse le seuil statutaire de 3% des actions émises par Ageas dans la case A (Droits de vote). Sa participation actuelle atteint 0,35%. Motif de la notifi...

 PRESS RELEASE

Ageas en The Goldman Sachs Group Inc: Transparantiekennisgeving

Ageas en The Goldman Sachs Group Inc: Transparantiekennisgeving The Goldman Sachs Group, Inc informeerde Ageas op 13 december 2024, overeenkomstig de financiële transparantievereisten*, dat zijn belang op 9 december 2024 onder de wettelijke drempel van 5% van de door Ageas uitgegeven aandelen is gedaald. Op 12 december 2024 informeerde het Ageas, dat zijn belang op 6 december 2024 onder de statutaire drempel van 3% van de door Ageas uitgegeven aandelen is gedaald in box A (stemrechten). Het huidige belang bedraagt 0,35%. Reden van de kennisgeving van 13 december 2024Verwerving of overdrach...

Lynn Hautekeete ... (+3)
  • Lynn Hautekeete
  • Michiel Declercq
  • Thomas Vranken
Thomas Vranken
  • Thomas Vranken

UCB Early-stage Parkinson's efforts tremble

UCB's efforts into the neurodegenerative space prove a tough nut to crack, as a Phase 2a study in early Parkinson's disease missed its primary and secondary endpoints. Oral small molecule minzasolmin was designed to address alpha-synuclein misfolding, one of the hallmarks of Parkinson's, but failed to show efficacy in the ORCHESTRA trial. We currently do not yet have strong hypotheses on the reasons of the failure (mechanism of action/drug/trial-related), but minza represented less than 1% of ou...

 PRESS RELEASE

Ageas reports on the progress of share buy-back programme

Ageas reports on the progress of share buy-back programme Ageas reports on the progress of share buy-back programme Further to the initiation of the share buy-back programme announced on 28 August 2024, Ageas reports the purchase of 147,476 Ageas shares in the period from 09-12-2024 until 13-12-2024. DateNumber ofSharesTotal amount(EUR)Average price(EUR)Lowest price(EUR)Highest price(EUR)09-12-202424,0611,142,40247.4847.3847.7810-12-202444,5002,091,97947.0146.8447.3811-12-202442,4162,001,61947.1946.8047.8212-12-202428,4991,342,16447.1046.8847.3213-12-20248,000380,73347.5947.0047.78Total14...

 PRESS RELEASE

Rapport d’Ageas sur le programme de rachat d’actions

Rapport d’Ageas sur le programme de rachat d’actions Rapport d’Ageas sur le programme de rachat d’actions Dans le cadre du programme de rachat d’actions annoncé le 28 août 2024, Ageas indique que 147.476 actions Ageas ont été achetées durant la période du 09-12-2024 au 13-12-2024. DateNombred’actionsMontant total(EUR)Cours moyen(EUR)Cours le plus bas (EUR)Cours le plus élevé (EUR)09-12-202424.0611.142.40247,4847,3847,7810-12-202444.5002.091.97947,0146,8447,3811-12-202442.4162.001.61947,1946,8047,8212-12-202428.4991.342.16447,1046,8847,3213-12-20248.000380.73347,5947,0047,78Total147.4766.95...

 PRESS RELEASE

Ageas rapporteert over de inkoop van eigen aandelen

Ageas rapporteert over de inkoop van eigen aandelen Ageas rapporteert over de inkoop van eigen aandelen Naar aanleiding van het aandelen-inkoopprogramma dat op 28 augustus 2024 aangekondigd werd, maakt Ageas bekend dat er 147.476 eigen aandelen ingekocht werden tussen 09-12-2024 en 13-12-2024. DatumAantalaandelenTotaal Bedrag(EUR)Gemiddelde koers(EUR)Laagste koers(EUR)Hoogste koers(EUR)09-12-202424.0611.142.40247,4847,3847,7810-12-202444.5002.091.97947,0146,8447,3811-12-202442.4162.001.61947,1946,8047,8212-12-202428.4991.342.16447,1046,8847,3213-12-20248.000380.73347,5947,0047,78Totaal147....

Carole Braudeau
  • Carole Braudeau

Credit Morning 12/16/2024

S&P downgrades Cheplapharm to B/Stable|

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch